[Antineoplastic chemotherapy for cervical carcinoma (author's transl)].
The effectiveness of antineoplastic substances on cervical carcinoma is insufficient. While combined chemotherapy was found to be more effective than monotherapy, satisfactory results were not achieved either. When it comes to recurrent or metastatic cervical carcinoma, antineoplastic chemotherapy, therefore, is not recommended unless all surgical and radiotherapeutic means have been tried with no success. Benefit to the patient and expected molestation should be carefully weighed, before a decision is made.
D001761:Bleomycin / Q000627:therapeutic use; D002945:Cisplatin / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008937:Mitomycins / Q000627:therapeutic use; D011379:Prognosis; D011788:Quality of Life; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy
D008937:Mitomycins; D001761:Bleomycin; D004317:Doxorubicin; D002945:Cisplatin
Antineoplastische Chemotherapie beim Zervixkarzinom.